Filter Results:
(354)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(354)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
- 27 Apr 2023
- News
Life Preserver
transplant organs from a few hours to a few days or possibly longer. "Eventually, we want to stop biological time," says Giwa, who is CEO of Sylvatica. (He left Ossium in 2018 but also is the cofounder and chairman of Elevian, a biotech... View Details
Keywords: April White
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different drugs are... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 19 Mar 2006
- Research & Ideas
Unlocking Your Investment Capital
Neither an asset's cost nor its size specifies its riskiness. For example, consider two assets, $1 billion of a single-drug biotech stock and $1 billion of U.S. Treasury bonds: Each has the same cost and size but they have radically... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
science-based research is something the heads of top biotech and pharmas learned long ago: There are few instant payoffs to please investors. Just ask Raymond Gilmartin, former chairman, president, and CEO of Merck & Co., who now... View Details
- 17 Dec 2001
- Research & Ideas
Enterprising Women
by the firm's mission and saw that it had been self-sufficient for nearly seven years, Fisher's task became much easier: In three stages, over the course of 2000, she raised venture capital funds of $11 million, $48 million, and $75 million. That same year, she founded... View Details
Keywords: by Julia Hanna
- 01 Mar 2019
- News
The Blue-Green Revolution
biotech company cofounded by genomics pioneer Craig Venter and Nobel Laureate Hamilton Smith, together with writer and life sciences investor Juan Enriquez (MBA 1986). And it may soon come to fruition: Last March, in the wake of a... View Details
- 08 Sep 2010
- First Look
First Look: September 8, 2010
for a cure; the doubts and obstacles he experiences along the way; and the current options Kremer faces, from returning home to spend time with family to founding a new biotech venture. Through this stark, realistic, and inspiring... View Details
Keywords: Sean Silverthorne
- 15 Dec 2020
- Blog Post
MBA Voices Blog: A Year in Review
decision maker. Read More 4 Things to Know About the MS/MBA Biotech “I was initially attracted to Harvard’s MS/MBA Biotechnology: Life Sciences program because of the emphasis on ethical decision making, and ultimately chose the program... View Details
- Web
Middle East & North Africa - Global Activities 2021
Graduate School of Arts and Sciences, and Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region.... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract... View Details
Keywords: Sean Silverthorne
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
prescription drugs that in 1992 it spun off its remaining chemical business to its stockholders. In addition, the American Cyanamid purchase included Immunex, one of the very few biotech startups that had surpassed $100 million in... View Details
- 01 Oct 2000
- News
The Entrepreneurial Venture
instance, who are the customers, and how do they make decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
MS/MBA Biotechnology: Life Sciences Program will build upon students’ existing biotech and life sciences knowledge and equip them with the latest business and scientific insights. The first cohort will start in August 2020. The joint... View Details
Keywords: Susan Young
- 26 Jan 2021
- News
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
sharing how they were tapped to confront the COVID crisis. “On the sixth of May, I got a call from the Prime Minister asking me to take on this role,” said Bingham, who leads biotech investments as Managing Partner at SV Health Investors.... View Details
Keywords: Margie Kelley
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
move to one of the big tech clusters like San Francisco,” Kerr says. “Likewise, if you are a biotech entrepreneur, there are enormous advantages to being in the Boston area. But there are also a lot of inventors who work in spaces that... View Details
Keywords: by Rachel Layne
- Web
Finalists | New Venture Competition
DoriVac (DNA Origami Vaccine) is a biotech startup for improving cancer treatment using a novel DNA nanoparticle platform. We develop treatments that teach patients' immune systems to recognize and fight cancer. Earthbond Chidalu Onyenso... View Details
- 22 Feb 2022
- News
An Rx for Small Business Recovery
cluster concept pioneered by Michael Porter, the Bishop William Lawrence University Professor (Renewal Leave) at HBS, Mills argues that organizing a region’s small and large businesses around specialized industries—such as biotech in... View Details
Keywords: Deborah Blagg
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details
Keywords: by James Heskett
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
while also preparing for the next pandemic. As COVID taught us, the more we prepare now, the quicker we can get back to normal when the next pandemic hits. As I look back at Vaxess years, it has been fantastic to see life sciences grow at HBS and within the Boston... View Details